Stock Events

Stock Events

Mind Medicine Inc 

$22.8
914
+$0.51+2.29% Today

Statistics

Day High
23.09
Day Low
22.46
52W High
23.68
52W Low
6.15
Volume
98,308,441
Avg. Volume
-
Mkt Cap
1.75B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

5MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.78
-0.55
-0.31
-0.08
Expected EPS
-0.496269
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-217.36MNet Income

Analyst Ratings

39.4Average Price Target
The highest estimate is 70.00.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MNMD. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.22B
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for depression, directly competing with Mind Medicine's psychedelic-based treatments.
AtaiBeckley
ATAI
Mkt Cap1.52B
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health, making it a direct competitor in the psychedelic medicine market.
GH Research
GHRS
Mkt Cap1.42B
GH Research is developing a novel therapeutic approach for mental health disorders using 5-MeO-DMT, competing in the same space as Mind Medicine's psychedelic-based treatments.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is involved in the development of psychedelic therapies, including psilocybin and MDMA, positioning it as a competitor in the psychedelic medicine industry.
Revive Therapeutics
RVVTF
Mkt Cap11.33M
Revive Therapeutics is exploring the use of psychedelics for the treatment of mental illness and addiction, competing in the same therapeutic space as Mind Medicine.
TripAdvisor
TRIP
Mkt Cap1.35B
Red Light Holland is focused on the production, growth, and sale of a premium brand of magic truffles, entering the broader market of psychedelic substances that Mind Medicine is also targeting.
Noveris Health Sciences
MYCOF
Mkt Cap48.92M
Mydecine Innovations Group is a biotech company focusing on the development of psychedelic therapies, making it a competitor in the emerging field of psychedelic medicine.

About

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Robert Barrow
Employees
74
Country
Canada
ISIN
CA60255C8850

Listings

STU
DE
MMQ0.STU
MU
DE
MMQ0.MU
F
DE
MMQ0.F
XNAS
US
DFTX

0 Comments

Share your thoughts

FAQ

What is Mind Medicine Inc stock price today?▼
The current price of MNMD is $22.8 USD — it has increased by +2.29% in the past 24 hours. Watch Mind Medicine Inc stock price performance more closely on the chart.
What is Mind Medicine Inc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mind Medicine Inc stocks are traded under the ticker MNMD.
Is Mind Medicine Inc stock price growing?▼
MNMD stock has risen by +11.37% compared to the previous week, the month change is a +51.93% rise, over the last year Mind Medicine Inc has showed a +261.65% increase.
What is Mind Medicine Inc market cap?▼
Today Mind Medicine Inc has the market capitalization of 1.75B
What is Mind Medicine Inc revenue for the last year?▼
Mind Medicine Inc revenue for the last year amounts to 0 USD.
What is Mind Medicine Inc net income for the last year?▼
MNMD net income for the last year is -217.36M USD.
How many employees does Mind Medicine Inc have?▼
As of May 06, 2026, the company has 74 employees.
In which sector is Mind Medicine Inc located?▼
Mind Medicine Inc operates in the Health & Wellness sector.
When did Mind Medicine Inc complete a stock split?▼
The last stock split for Mind Medicine Inc was on August 29, 2022 with a ratio of 1:15.
Where is Mind Medicine Inc headquartered?▼
Mind Medicine Inc is headquartered in New York, Canada.